Research and development services - development of a thermoresponsive, bioadhesive topical GEL for prevention of combat-related extremity wound infections
Ended Definitive Contract Awarded Last action
- Contract number
- HT942524C0091
- Awardee
-
Wake Forest University Health Sciences UEI SN7KD2UK7GC5 Part of Wake Forest University
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $732,024
Award facts
- Opportunity
-
- HT942524R0084 Solicitation number
- Contract value 100% obligated
- $732,024.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Air Education and Training Command Air Force, Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Winston-Salem, NC 27157, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $732,024 |
About this award
Wake Forest University Health Sciences was awarded a $732,024 definitive contract on September 26, 2024, by the Air Education and Training Command to develop a thermoresponsive, bioadhesive topical gel containing omadacycline and polymixin B for prevention of combat-related extremity wound infections. This research and development effort, which will be performed in Winston-Salem, North Carolina, represents a firm fixed-price engagement with an ultimate completion date of March 25, 2026. The contract was not issued under any set-aside designation, reflecting the institution's broad technical and research capabilities. As a leading academic medical center and research institution, Wake Forest University Health Sciences brings specialized expertise in medical technology development and biomedical innovation to support military medical readiness and advancement of combat casualty care solutions.
The project aligns with the Department of Defense's commitment to advancing medical countermeasures and treatment modalities for battlefield injuries. Wake Forest University Health Sciences, a child entity of Wake Forest University, has an established track record executing complex federal contracts and grants across diverse biomedical research domains for agencies including the Department of Veterans Affairs, National Institutes of Health, and various Department of Defense commands. The parent institution holds several significant federal research vehicles and has demonstrated capabilities in medical training, clinical trials, and innovative healthcare solutions that support both military and civilian medical advancement priorities.
Quick answers
Who was awarded contract HT942524C0091?
HT942524C0091 was awarded to Wake Forest University Health Sciences by Defense Health Agency (Department of Defense) on September 26, 2024.
How much is contract HT942524C0091 worth?
The government has obligated $732,024 on HT942524C0091.
Which agency awarded contract HT942524C0091?
Defense Health Agency (Department of Defense) awarded HT942524C0091, with funding from Air Education and Training Command (Air Force).
Was contract HT942524C0091 competed?
The extent of competition for HT942524C0091 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award